Elanco Animal Health Incorporated (ELAN)
Elanco Animal Health Incorporated at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Elanco Animal Health Incorporated (ELAN) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $12B. Revenue grew 6.2% year-over-year and the company generated $284M in free cash flow. This page tracks ELAN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 9K employees · IPO Sep 20, 2018
Valuation
Valuation & price
$19.86as of May 17, 2026· -26.0% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.83
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$12B
Market cap
6.2%
Revenue growth (YoY)
43.5%
Gross margin
$284M
Free cash flow (USD)
$3.5B
Net debt
0.5%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
2
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 6, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventMay 27, 2026Filing
Annual Meeting Results
- Insider buyMay 19, 2026Filing
Insider Buy $100KSimmons Jeffrey N · Director, PRESIDENT, CEO AND DIRECTOR · $99.8K
- Insider buyMay 19, 2026Filing
Insider Buy $100KModi Rajeev A. · SEE REMARKS · $99.9K
- 8-K eventMay 6, 2026Filing
Earnings Release
- Quarterly reportMay 6, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is Elanco Animal Health Incorporated's market cap?
Elanco Animal Health Incorporated (ELAN) has a market capitalization of $12B.
What is ELAN's P/E ratio?
A meaningful P/E ratio is not available for ELAN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ELAN's price-to-book (P/B) ratio?
ELAN trades at 1.83 times book value per share.
Are insiders buying ELAN stock?
Yes — SEC Form 4 filings show 2 open-market insider buys and 0 sells at Elanco Animal Health Incorporated in the last 90 days.
Same arena
Related companies in Drug Manufacturers - Specialty & Generic
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.